PATENT CLAIM ANALYSIS

Application Number: 15907480
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "006000"]

Abstract:
Provided herein are opto-genetic systems, cells, and methods thereof for modulating and regulating genetic expression in transiently active cells. The technologies described herein provide a transformative genetic regulatory tool for in vivo applications, which broadly spans a variety of disciplines, including behavioral, cognitive, and systems neuroscience.

Claim (Index 7):
The system of  claim 5 , wherein the sequence-specific DNA binding domain comprises the DNA-binding domain of a transcription factor selected from the group consisting of GAL4, GCN4, Thy1, Syn1, NSE/RU5\u2032, Agrp, Calb2, Camk2a, CcK, Chat, dlx6a and Emx1.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15036020', '14105017', '12771457', '14004879', '11115922']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6578604936629143
- 35 USC 102 Novelty (BERT): 0.5010450949070133
- Combined Prediction Score: 0.6421789537873243
- Mean Citation Score: 255.01408
- Max Citation Score: 261.08667
- Similarity Product: 178.39716500434398

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test